Showing results (51-60 of 85) with videos related to
Sort By:
Pageof 9
The Journal of Urology|July 1, 1995
Intravesical recombinant tumor necrosis factor in the treatment of superficial bladder cancer: an Eastern Cooperative Oncology Group studyD B Glazier, R R Bahnson, D G McLeod, et al.The Journal of Urology|February 1, 1996
5-fluorouracil and allopurinol combined with recombinant interferon-alpha 2b in the treatment of patients with advanced prostate cancer: a phase I/II studyD B Glazier, J A Heaney, R J Amdur, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 14, 2000
Adjuvant therapy of stage III and IV malignant melanoma using granulocyte-macrophage colony-stimulating factorL E Spitler, M L Grossbard, M S Ernstoff, et al.Clinical and Experimental Immunology|December 9, 1998
Inflammatory cell infiltrate in a responding metastatic nodule after vaccine-based immunotherapyT F Logan, B Banner, U Rao, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1987
A randomized phase I/II study of continuous versus intermittent intravenous interferon gamma in patients with metastatic melanomaM S Ernstoff, T Trautman, C A Davis, et al.Urology|February 1, 1992
Interferon-induced reversible acute renal failure with nephrotic syndromeS Nair, M S Ernstoff, R R Bahnson, et al.The Journal of Urology|December 1, 1991
Immunohistochemical localization of metallothionein in transitional cell carcinoma of the bladderR R Bahnson, B F Banner, M S Ernstoff, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2001
High-dose interferon alfa-2b significantly prolongs relapse-free and overall survival compared with the GM2-KLH/QS-21 vaccine in patients with resected stage IIB-III melanoma: results of intergroup trial E1694/S9512/C509801J M Kirkwood, J G Ibrahim, J A Sosman, et al.The American Journal of Surgical Pathology|December 1, 1996
Tissue-shrinkage correction factor in the calculation of prostate cancer volumeA R Schned, K J Wheeler, C A Hodorowski, et al.Journal of Biological Response Modifiers|August 1, 1990
Toxicity of intravesical recombinant human tumor necrosis factor in cynomolgus monkeysR R Bahnson, B T Ballou, M S Ernstoff, et al.Pageof 9